Vertex Pharmaceuticals, Inc (NASDAQ:VRTX) currently has a daily average trading volume of 1.74M but it saw 1209533 shares traded in last market. With a market cap of 114.30B USD, the company’s current market price of $445.10 came falling about -0.20 while comparing to the previous closing price of $446.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $519.88 and as low as $377.85. In the recent trading on the day, stock has struck highest price mark of $443.405 while lowest mark touched by it was $451.635.
Leerink Partners downgraded its recommendation for the stock as a “Market Perform” from “Outperform” on May 06, 2025 while assigning a price target of $503. Cantor Fitzgerald issued its recommendations for the stock as it resumed the price target for the stock is $535.
Over the week, VRTX’s stock price is moving -0.47% down while it is -10.35% when we observe its performance for the past one month. Year-to-date it is 10.53% up and over the past year, the stock is showing a downside performance of -1.26%.
Currently, Vertex Pharmaceuticals, Inc’s total number of outstanding shares is 256.97M with 0.16% of that held by the insiders while 97.87% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -5.45% and return on equity (ROE) at -5.64%. It has a 21.39 of forward P/E ratio. Stock’s beta reads 0.43. Stock has a price to book (P/B) ratio of 6.93 while price to sale or P/S ratio amounts to 10.35. Its return on asset (ROA) is -4.23% on average.
